Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14720608 | 0.73 | HRH3 (0.43) | HRH3SRD5A2 | |
| SCHEMBL14720518 | 0.72 | HRH3 (0.46) | HRH3 | |
| SCHEMBL14721067 | 0.72 | SRD5A2 (0.42) | HRH3SRD5A2 | |
| SCHEMBL14720734 | 0.71 | SRD5A2 (0.34) | HRH3SRD5A2 | |
| SCHEMBL14720720 | 0.71 | SRD5A2 (0.58) | HRH3SRD5A2 | |
| SCHEMBL14720746 | 0.71 | HRH3 (0.38) | HRH3 | |
| SCHEMBL14720802 | 0.70 | HRH3 (0.39) | HRH3SRD5A2 | |
| Hydrochloric Acid SCHEMBL14721345 | 0.70 | SRD5A2 (0.57) | HRH3SRD5A2 | |
| SCHEMBL14720522 | 0.70 | HRH3 (0.39) | HRH3SRD5A2 | |
| SCHEMBL14721775 | 0.70 | HRH3 (0.43) | HRH3SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | claimed |
| EP-2748331-A1 | SUSCEPTIBILITY TO SELECTIVE CDK9 INHIBITORS | Lead Discovery Center GmbH (DE) | 2014-07-02 | — | — | EP | disclosed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013026890-A1 | SUSCEPTIBILITY TO SELECTIVE CDK9 INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |